![Christopher P. Prior](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher P. Prior
Chief Executive Officer at InterAx Biotech AG
Christopher P. Prior active positions
Companies | Position | Start | End |
---|---|---|---|
New York Academy of Sciences
![]() New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
InterAx Biotech AG
![]() InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services InterAx Biotech AG engages in assisting drug candidate design and selection. It focuses on the development of its systems biology platform. The company was founded by Martin Ostermaier, Aurelien Rizk, and Luca Zenone and is headquartered in Villigen, Switzerland. | Chief Executive Officer | 23/01/2023 | - |
Career history of Christopher P. Prior
Former positions of Christopher P. Prior
Companies | Position | Start | End |
---|---|---|---|
9 METERS BIOPHARMA, INC. | Director/Board Member | 31/12/2014 | 18/02/2019 |
Chief Executive Officer | 31/12/2014 | 18/02/2019 | |
PHASEBIO PHARMACEUTICALS, INC. | Director/Board Member | 31/03/2008 | 31/08/2014 |
Chief Executive Officer | 31/03/2008 | 31/08/2014 | |
Innovate Biopharmaceuticals, Inc. /Old/
![]() Innovate Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Innovate Biopharmaceuticals, Inc. manufactures pharmaceutical products. It develops INN-329, a phase III clinical stage solution for magnetic resonance cholangiopancreatography; and Secretin stimulated MRCP, a non-invasive, ionizing, and radiation-free assessment of the pancreaticobiliary system. The company is headquartered in Raleigh, NC. | Chief Executive Officer | - | - |
Principia Pharmaceutical Corp
![]() Principia Pharmaceutical Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Principia Pharmaceutical Corp is a derivatives industry analysis company that examines valuation, risk management, and operational requirements for derivatives end users. The company is based in Norristown, PA. Principia Pharmaceutical was acquired by Human Genome Sciences, Inc., part of GSK Plc from August 03, 2012 on September 11, 2000 for $120 million. The company also provides fixed income and structured credit investor research and whitepaper downloads. The company was founded by Christopher P. Prior. | Founder | - | - |
President | - | - | |
Rhône Poulenc Pharma, Inc. | Chief Tech/Sci/R&D Officer | - | - |
Orchestra Therapeutics, Inc.
![]() Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Corporate Officer/Principal | - | - |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - | - |
░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Christopher P. Prior
The Trustees of Columbia University in The City of New York | Doctorate Degree |
University of London | Undergraduate Degree |
Statistics
International
United States | 10 |
United Kingdom | 2 |
Canada | 2 |
Operational
Chief Executive Officer | 4 |
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
9 METERS BIOPHARMA, INC. | Health Technology |
Private companies | 8 |
---|---|
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Orchestra Therapeutics, Inc.
![]() Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Finance |
Principia Pharmaceutical Corp
![]() Principia Pharmaceutical Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Principia Pharmaceutical Corp is a derivatives industry analysis company that examines valuation, risk management, and operational requirements for derivatives end users. The company is based in Norristown, PA. Principia Pharmaceutical was acquired by Human Genome Sciences, Inc., part of GSK Plc from August 03, 2012 on September 11, 2000 for $120 million. The company also provides fixed income and structured credit investor research and whitepaper downloads. The company was founded by Christopher P. Prior. | Health Technology |
BioRexis Pharmaceutical Corp.
![]() BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
New York Academy of Sciences
![]() New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Commercial Services |
Rhône Poulenc Pharma, Inc. | |
Innovate Biopharmaceuticals, Inc. /Old/
![]() Innovate Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Innovate Biopharmaceuticals, Inc. manufactures pharmaceutical products. It develops INN-329, a phase III clinical stage solution for magnetic resonance cholangiopancreatography; and Secretin stimulated MRCP, a non-invasive, ionizing, and radiation-free assessment of the pancreaticobiliary system. The company is headquartered in Raleigh, NC. | Health Technology |
InterAx Biotech AG
![]() InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services InterAx Biotech AG engages in assisting drug candidate design and selection. It focuses on the development of its systems biology platform. The company was founded by Martin Ostermaier, Aurelien Rizk, and Luca Zenone and is headquartered in Villigen, Switzerland. | Commercial Services |
- Stock Market
- Insiders
- Christopher P. Prior
- Experience